RA
Actavia Life Sciences, Inc.
RASP · OTC
$0.00 +0.00% (+$0.00)
Market Cap $385.9K
P/E Ratio -
Div. Yield -
ROE -
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
1/9Valuation
-
N/A P/E N/A
PEG N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
57 /100
Average ROIC 242.88%
Asset turnover 0.00x
ROA 4,644.72%
Debt
0 /100
High Current ratio 0.05x
Int. coverage -19.86x
Debt/Equity N/A
Stability
32 /100
Unstable Beta -6.96x
Profitable years 0
EPS volatility 55.32%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RASP
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Keeren Shah
Employees
1
Headquarters
New York City